Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/307% below fair value
$3.38−0.03 (-0.88%)
Close on Nov 13, 2026Market cap $1.25BP/E 19.9Yield –
Earnings
Cronos's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 25, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$63.50M
+74.9% on a year earlier
EPS, Q3 FY2026
$0.04
$0.07 a year earlier
Latest guidance
Reaffirmed
Nov 12, 2024 · 1 item
Quarterly results
Revenue and earnings per share from each of Cronos's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 25, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026before the open | $63.50M | +74.9% | $0.04 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026before the open | $53.00M | – | $0.09 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 11, 2026before the open | $45.20M | +39.9% | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 26, 2026before the open | $44.50M | +46.9% | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025before the open | $36.30M | +5.8% | $0.07 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025before the open | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025before the open | $32.30M | +27.7% | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 27, 2025before the open | $30.30M | +26.8% | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024before the open | $34.30M | +38.3% | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024before the open | $27.80M | +46.3% | -$0.02 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024before the open | $25.30M | +25.9% | -$0.01 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 29, 2024before the open | $23.90M | +4.4% | -$0.12 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 8, 2023before the open | $24.80M | +18.7% | $0.00 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023before the open | $19.00M | -17.7% | -$0.02 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023before the open | $20.10M | -19.6% | -$0.05 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 28, 2023before the open | $22.90M | +12.3% | -$0.21 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 7, 2022before the open | $20.90M | – | -$0.10 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 9, 2022before the open | $23.10M | – | -$0.05 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 10, 2022before the open | $25.00M | – | -$0.09 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 18, 2022before the open | $20.40M | – | $0.21 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 6, 2021before the open | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 7, 2021before the open | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 26, 2021before the open | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 5, 2020before the open | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 6, 2020before the open | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Cronos guided for has been reported
Guidance history
Every forecast Cronos put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 12, 2024 | operating expense savings target | FY2024 | $5.00M – $10.00M | Reaffirmed |
| Aug 8, 2024 | operating expense savings target | FY2024 | $5.00M – $10.00M | Lowered |
| May 9, 2024 | operating expense savings target | FY2024 | $5.00M – $10.00M | Lowered |
| May 9, 2024 | anticipated interest income | FY2024 | $40.00M – $50.00M | Raised |
| Feb 29, 2024 | operating expense savings | FY2024 | $5.00M – $10.00M | Lowered |
| Feb 29, 2024 | interest income | FY2024 | $40.00M – $50.00M | Raised |
| Nov 8, 2023 | net change in cash decline | Q4 FY2023 | $5.00M – $10.00M | New |
| Nov 8, 2023 | operating expense savings target | FY2023 | $20.00M – $25.00M | Reaffirmed |
| Nov 8, 2023 | planned incremental operating expense savings | FY2024 | $10.00M – $15.00M | Reaffirmed |
| Aug 8, 2023 | operating expense savings target | FY2023 | $20.00M – $25.00M | Raised |
| Aug 8, 2023 | net change in cash | FY2023 | $5.00M – $10.00M | Lowered |
| Aug 8, 2023 | interest income | FY2023 | $20.00M – $25.00M | Raised |
| Aug 8, 2023 | full-year savings | FY2024 | $10.00M – $15.00M | New |
| May 9, 2023 | Net revenue | FY2023 | $100.00M – $110.00M | New |
| Feb 28, 2023 | operating expense savings | FY2023 | $10.00M – $20.00M | New |
| Nov 7, 2022 | operating expense savings | FY2022 | $20.00M – $25.00M | Reaffirmed |
| Feb 18, 2022 | initially identified savings across operating expense categories | FY2022 | $20.00M – $25.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Cronos filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
See a number that looks wrong?